Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001839882-25-007658·Evolus, Inc.
Schedule 13G ownership disclosure
Evolus Inc
Common stock, par value $0.00001 per share · CUSIP: 30052C107
Event date: 2024-12-31
- Filing-level shares
- 2,136,449.00
- Percent of class
- 3.4%
- Medytox Inc.
Shares: 2,136,449.00 · Class: 3.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001839882-25-007658
- Form type
- SCHEDULE 13G/A
- Filer
- Evolus, Inc.
- CIK
- CIK 1570562
- Filed
- Feb 06, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership